{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:12:08Z","timestamp":1674627128362},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.optm.2005.07.003","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T11:17:27Z","timestamp":1128079047000},"page":"526-535","source":"Crossref","is-referenced-by-count":6,"title":["Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management"],"prefix":"10.1016","volume":"76","author":[{"given":"M. Tariq","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall L.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9349","key":"10.1016\/j.optm.2005.07.003_bib1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","article-title":"Management of acute optic neuritis","volume":"360","author":"Hickman","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1091-8531(99)70078-9","article-title":"Optic neuritis in children","volume":"3","author":"Brady","year":"1999","journal-title":"J AAPOS"},{"issue":"5","key":"10.1016\/j.optm.2005.07.003_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","article-title":"Risk factors for developing multiple sclerosis after childhood optic neuritis","volume":"49","author":"Lucchinetti","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.optm.2005.07.003_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.optm.2005.07.003_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2741\/1267","article-title":"Neuromyelitis optica","volume":"9","author":"Wingerchuk","year":"2004","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.optm.2005.07.003_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(13)31589-9","article-title":"Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial","volume":"100","author":"Beck","year":"1993","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.optm.2005.07.003_bib7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(95)30839-1","article-title":"What we have learned from the Optic Neuritis Treatment Trial","volume":"102","author":"Beck","year":"1995","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.optm.2005.07.003_bib8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.optm.2005.07.003_bib9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archopht.1997.01100160578009","article-title":"Does optic disc appearance distinguish ischemic optic neuropathy from optic neuritis?","volume":"115","author":"Warner","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Multiple sclerosis-associated uveitis","volume":"12","author":"Zein","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00041327-199506000-00002","article-title":"Uhthoff and his symptom","volume":"15","author":"Selhorst","year":"1995","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.410300209","article-title":"Uhthoff\u2019s symptom in optic neuritis","volume":"30","author":"Scholl","year":"1991","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.optm.2005.07.003_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.optm.2005.07.003_bib14","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","article-title":"Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen","year":"1996","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.optm.2005.07.003_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archneur.1993.00540080050013","article-title":"Brain magnetic resonance imaging in acute optic neuritis","volume":"50","author":"Beck","year":"1993","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.optm.2005.07.003_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-6420(92)31892-5","article-title":"Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging","volume":"99","author":"Guy","year":"1992","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.optm.2005.07.003_bib17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(02)01148-X","article-title":"Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Rizzo","year":"2002","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.optm.2005.07.003_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.optm.2005.07.003_bib19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.optm.2005.07.003_bib20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0161-6420(99)90482-7","article-title":"The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists","volume":"106","author":"Trobe","year":"1999","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.optm.2005.07.003_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis","volume":"137","author":"Beck","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.optm.2005.07.003_bib22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archopht.1997.01100160715008","article-title":"Visual function 5 years after optic neuritis","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.optm.2005.07.003_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial","volume":"49","year":"1997","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.optm.2005.07.003_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.optm.2005.07.003_bib25","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/WNL.54.11.2039","article-title":"Practice parameter","volume":"54","author":"Kaufman","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.optm.2005.07.003_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis","volume":"247","author":"Brusaferri","year":"2000","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.55.2.186","article-title":"Optic neuritis in African Americans","volume":"55","author":"Phillips","year":"1998","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.optm.2005.07.003_bib28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","article-title":"A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis","volume":"56","author":"Noseworthy","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/WNL.38.2.185","article-title":"Risk of developing multiple sclerosis after uncomplicated optic neuritis","volume":"38","author":"Rizzo","year":"1988","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.optm.2005.07.003_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"12 Suppl 5","key":"10.1016\/j.optm.2005.07.003_bib31","first-page":"S36","article-title":"The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. 1997","volume":"57","year":"2001","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.optm.2005.07.003_bib32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archneur.61.9.1386","article-title":"Neurologic impairment 10 years after optic neuritis","volume":"61","author":"Beck","year":"2004","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.optm.2005.07.003_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.optm.2005.07.003_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/01.WNL.0000095425.84407.39","article-title":"The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis","volume":"61","author":"Goodin","year":"2003","journal-title":"Neurology"},{"issue":"12 Suppl 6","key":"10.1016\/j.optm.2005.07.003_bib35","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.63.12_suppl_6.S8","article-title":"Current approved options for treating patients with multiple sclerosis","volume":"63","author":"Rizvi","year":"2004","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.optm.2005.07.003_bib36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.optm.2005.07.003_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","article-title":"Interferon beta-1a for early multiple sclerosis","volume":"51","author":"Beck","year":"2002","journal-title":"Ann Neurol"},{"issue":"9268","key":"10.1016\/j.optm.2005.07.003_bib38","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152918390500062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152918390500062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:54:37Z","timestamp":1548122077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152918390500062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S152918390500062X"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2005.07.003","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}